APVO - CIK 0001671584
The table below shows Aptevo Therapeutics Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $21.62M | $8.71M | $16.90M | $22.64M | $45.04M | $39.98M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $23.08M |
| $10.66M |
| $19.07M |
| $27.45M |
| $52.57M |
| $47.26M |
| Property, plant & equipment | $303.00K | $543.00K | $895.00K | $1.46M | $2.38M | $2.81M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $27.19M | $15.59M | $24.84M | $34.22M | $56.60M | $53.55M |
| Accounts payable | $877.00K | - | - | - | - | - |
| Total current liabilities | $6.05M | $6.21M | $7.22M | $8.71M | $34.76M | $14.54M |
| Long-term debt | - | - | $1.46M | $1.46M | - | - |
| Total liabilities | $9.81M | $10.84M | $12.62M | $16.24M | $55.38M | $36.95M |
| Retained earnings | -$275.12M | -$247.58M | -$223.45M | -$206.04M | -$214.06M | -$185.61M |
| Total equity | $17.38M | $4.75M | $12.22M | $17.97M | $1.22M | $16.59M |